New pill shows promise for Hard-to-Treat brain cancers

NCT ID NCT06047379

First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 22 times

Summary

This study tests an experimental oral drug called NEO212 in people with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control the disease. About 134 adults will take part across two phases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor, Scott and White Research Institute

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact

    Contact Email: •••••@•••••

  • Northwest Medical Specialties

    RECRUITING

    Tacoma, Washington, 98405, United States

    Contact

    Contact Phone: •••-•••-••••

  • OPN Healthcare, Inc

    RECRUITING

    Glendale, California, 91203, United States

    Contact Email: •••••@•••••

    Contact

  • Precision NextGen Oncology

    RECRUITING

    Beverly Hills, California, 90212, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Southern California

    RECRUITING

    Los Angeles, California, 90033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact

Conditions

Explore the condition pages connected to this study.